PP

Pulmonary Pharmacology & Therapeutics

Pulmonary Pharmacology & Therapeutics is a hybrid journal focused on lung pharmacology from molecular to clinical aspects, covering major lung diseases, drug delivery, pulmonary toxicology, and related laboratory and clinical research in humans and animals. The journal considers original research papers, review articles, and book reviews, and applies immediate rejection criteria for out-of-scope, preliminary, unethical, insufficiently detailed, or non-novel studies.

Looking to publish in Pulmonary Pharmacology & Therapeutics? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Pharmacology & Pharmacy, Respiratory System
Impact Factor 2.8
Quartile Q2
Open Access Type Hybrid
ISSN 1094-5539
Invitation Only No
Cost Range Open Access APC: USD 3,680 (excluding taxes); subscription publication: no publication fee charged to authors.

Submission Instructions

Pulmonary Pharmacology & Therapeutics accepts the following article types. Click on an article type to view submission instructions.

Research Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required for Research Articles. Abstract must not exceed 250 words. Abstract must clearly state the objective or hypothesis, primary results, and conclusion.
Manuscript Manuscript must be limited to 4,000 words including Introduction, Materials and Methods, Results, and Discussion, excluding title, abstract, table and figure legends, and references. Manuscript must be divided into clearly defined numbered sections and include Introduction, Materials and Methods, Results, and a Discussion that places the findings in context, addresses study limitations, and gives an overall conclusion. Manuscript must include 1 to 7 keywords in English, and any use of AI or AI-assisted tools in the research design or methods must be described reproducibly in the Methods section with the model or tool name, version or extension numbers, and manufacturer.
References Reference list must contain no more than 50 references. References must be cited using numerical citations in square brackets in the text. References must be numbered in the order of appearance and include author names, source title, article or chapter title, year, and volume with article number or pagination where applicable.
Figures & Tables Research Articles must have no more than 8 figures and tables combined. Figures must be uploaded as separate files, whereas tables must be provided as editable text files. All figures and tables must be cited in the text, numbered consecutively in order of appearance, and provided with captions.
Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Full Length Articles

Cover Letter Cover Letter requirements are not specified.
Abstract An abstract is required for Full Length Articles. Abstract must not exceed 250 words. Abstract must be unstructured. Abstract must clearly state the objective or hypothesis, primary results, and conclusion.
Manuscript Manuscript must be limited to 4,000 words excluding the title, abstract, table and figure legends, and references. Manuscript must be divided into clearly defined numbered sections including Introduction, Materials and Methods, Results, and Discussion. Manuscript must include 1 to 7 English keywords, and any AI or AI-assisted tools used in the research design or methods must be disclosed in the Methods section with the model or tool name, version or extension numbers, and manufacturer.
References Reference list must contain no more than 50 references. References must be cited as numbered references in square brackets in the text. References must be numbered in the order of appearance and include author names, source title information, year, and volume and page or article numbers where applicable.
Figures & Tables The combined total of figures and tables must not exceed 8. Figures must be uploaded as separate files, while tables are to be submitted as editable text with captions and cited in the manuscript. Figures and tables must be numbered consecutively in the order cited in the text, and each must have a caption.
Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not exceed 200 words.
Manuscript Manuscript must not exceed 6,000 words excluding the title, abstract, table and figure legends, and references. Article must be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 keywords in English, and any use of AI or AI-assisted tools as part of the research design or methods must be described in the methods section with the model or tool name, version or extension numbers, and manufacturer.
References References must not exceed 80. References must be cited by number in square brackets. References must be numbered in the order they appear in the article and include author names, source title, year, and volume and page or article number where applicable.
Figures & Tables Review may include up to 8 figures and tables in total. Figures must be uploaded as separate files, whereas tables are submitted within the manuscript as editable text. All figures and tables must be cited in the text, numbered consecutively, and accompanied by captions.
Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Short Communications

Cover Letter Cover Letter requirements are not specified.
Abstract Short Communications must include an abstract. Abstract must not exceed 250 words.
Manuscript Short Communications should be no longer than 2,000 words. Article must be divided into clearly defined and numbered sections. Manuscript must include 1 to 7 keywords in English, and any use of AI or AI-assisted tools as part of the research design or methods must be described in the methods section with the model or tool name, version or extension numbers, and manufacturer.
References Short Communications must have a maximum of 20 references. References must be indicated by a number within square brackets in the text. References may use any consistent submission style but must be numbered in order of appearance and include the required bibliographic details.
Figures & Tables Short Communications must have no more than 4 figures/tables combined. Figures must be supplied as separate files, whereas tables must be submitted as editable text. All figures and tables must be cited in the manuscript text, numbered in order of appearance, and include captions.
Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Letter To The Editor

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract must not be included.
Manuscript Manuscript must be no longer than 1,000 words.
References References must not exceed 10. References must be cited as numbers in square brackets in the text. References must be numbered in the order they appear in the article and may be submitted in any consistent style or format.
Figures & Tables Figures and tables must total no more than 2 combined. Figures must be supplied as separate files, while tables are submitted within the manuscript as editable text. Tables must include captions and be cited in the text, and figures must each have a caption and be cited in the text.
Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Recent Publications

Pulmonary safety of Staccato alprazolam in healthy participants and participants with mild asthma: Phase 1, randomized, double-blind, placebo-controlled trial

S. David Miller, Craig F. LaForce, Laura Barlow, Shikiko Watanabe, Aliceson King, Maria Burian, Hugues Chanteux

10.1016/j.pupt.2026.102411
View Publication

Nicotinamide N-oxide alleviates sepsis-induced acute lung injury by inhibiting ferroptosis through activation of the SIRT1/AKT signalling pathway

Shujuan Liu, Mian Fu, Xiguang Liu, Yichen Jin, Liwen Fan, Qingyan Ni, Zihan Xu, Yusa Li, Jiawen Zhou, Huizhen Chen

10.1016/j.pupt.2026.102419
View Publication

Evaluation of the effect of modulator therapies on medication complexity in adult cystic fibrosis patients

Esen Deniz Akman Ar, Nadir Yalçın, Uğur Balaban, Oğuz Karcıoğlu, Ebru Damadoğlu, Ali Fuat Kalyoncu, Kutay Demirkan

10.1016/j.pupt.2026.102420
View Publication

Evodiamine protects against lung ischemia–reperfusion injury by attenuating SYK-associated TLR4/NLRP3 inflammasome activation and ferroptosis-related injury signatures

Wei Peng, Baiping Ge, Rui Zhang, Yunen Liu, Changci Tong, Chenguang Dong

10.1016/j.pupt.2026.102421
View Publication

Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH)

Sheryl E. Wu, Jeremy A. Mazurek, Jennalyn D. Mayeux, Naomi G. Habib, Gurinderpal S. Doad, Christina K. Benninger, Michelle C. Cho, Paul M. Strachan, Richard M. Perry, Daisy Bridge, Medi A. Stone, Charlotte W. Oswald, Luis Val-Maranes, J. Wesley McConnell

10.1016/j.pupt.2025.102406
View Publication

Frequently asked questions

How long does it take to publish?

16 days from submission to first decision; 85 days from submission to decision after review; 131 days from submission to acceptance; 2 days from acceptance to first online publication.

Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

What are the publication costs?

Open Access APC: USD 3,680 excluding taxes. Subscription publication has no publication fee charged to authors.

Reformat to Pulmonary Pharmacology & Therapeutics using Livewrite Premium

Research Topics

Asthma and respiratory diseases Respiratory and Cough-Related Research Chronic Obstructive Pulmonary Disease (COPD) Research Inhalation and Respiratory Drug Delivery Respiratory Support and Mechanisms Neonatal Respiratory Health Research Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Pulmonary Hypertension Research and Treatments Diverse Scientific and Economic Studies Human auditory perception and evaluation Neuroscience of respiration and sleep Allergic Rhinitis and Sensitization Ion Channels and Receptors Educational Robotics and Engineering Nitric Oxide and Endothelin Effects Pediatric health and respiratory diseases Neuropeptides and Animal Physiology Receptor Mechanisms and Signaling Cystic Fibrosis Research Advances Pneumonia and Respiratory Infections Immune Response and Inflammation Pharmacological Effects and Assays Phosphodiesterase function and regulation Heart Failure Treatment and Management Mast cells and histamine

Related Journals

IJ
International Journal Of Tuberculosis And Lung Disease International Union Against Tuberculosis and Lung Disease
RM
Respiratory Medicine And Research Elsevier BV
TA
Thoracic And Cardiovascular Surgeon Georg Thieme Verlag
AA
Anaesthesia And Intensive Care Medicine Elsevier BV
BP
Bmc Pulmonary Medicine BioMed Central
ER
European Respiratory Journal European Respiratory Society